Display options
Cite
Stoyanova T, Goldstein AS. Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types. Cancer Cell Microenviron. 2014;1(3)doi: 10.14800/ccm.90.
Stoyanova, T., & Goldstein, A. S. (2014). Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types. Cancer cell & microenvironment, 1(3), . https://doi.org/10.14800/ccm.90
Stoyanova, Tanya, and Goldstein, Andrew S. "Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types." Cancer cell & microenvironment vol. 1,3 (2014). doi: https://doi.org/10.14800/ccm.90
Stoyanova T, Goldstein AS. Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types. Cancer Cell Microenviron. 2014;1(3). doi: 10.14800/ccm.90. PMID: 26005704; PMCID: PMC4441270.
Copy Download .nbib Format: NLM
Share it on

Cancer Cell Microenviron. 2014;1(3). doi: 10.14800/ccm.90.

Distinct phases of human prostate cancer initiation and progression can be driven by different cell-types.

Cancer cell & microenvironment

Tanya Stoyanova, Andrew S Goldstein

Affiliations

  1. Microbiology Immunology and Molecular Genetics, University of California, Los Angeles, CA 90095.
  2. Departments of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095 ; Departments of Urology, University of California, Los Angeles, CA 90095 ; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 ; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095.

PMID: 26005704 PMCID: PMC4441270 DOI: 10.14800/ccm.90

Abstract

The cells that initiate and propagate cancer are important therapeutic targets. However, the progression from cells of origin to tumor-propagating cells is poorly defined for most human cancers. Mouse models indicate that both basal and luminal cells can initiate prostate cancer, while studies with human prostate tissue have demonstrated a role for basal cells in transformation. Our recent study provides evidence that a common cell of origin can produce alternative variants of human epithelial cancer. Our findings also reveal that the cell of origin that initiates cancer is not continuously required to maintain and propagate the disease. Importantly, the cells responsible for initiating human prostate cancer can have a distinct cellular phenotype from the cells needed to maintain it.

Keywords: basal-like cells; epithelial cells; prostate cancer; tumor-propagating cells

References

  1. Science. 2012 Aug 10;337(6095):730-5 - PubMed
  2. Nature. 2012 Aug 23;488(7412):522-6 - PubMed
  3. Nature. 2006 Aug 17;442(7104):818-22 - PubMed
  4. Proc Natl Acad Sci U S A. 2011 May 3;108(18):7425-30 - PubMed
  5. Nature. 2013 Sep 19;501(7467):328-37 - PubMed
  6. Nature. 1994 Feb 17;367(6464):645-8 - PubMed
  7. Mol Oncol. 2010 Oct;4(5):385-96 - PubMed
  8. Genes Dev. 2013 Jul 15;27(14):1539-44 - PubMed
  9. Proc Natl Acad Sci U S A. 2011 May 3;108(18):7431-6 - PubMed
  10. Cancer Cell. 2012 Feb 14;21(2):253-65 - PubMed
  11. Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E592-600 - PubMed
  12. Nature. 2011 Jan 20;469(7330):314-22 - PubMed
  13. Nature. 2009 Jan 29;457(7229):608-11 - PubMed
  14. Nature. 2008 Apr 3;452(7187):650-3 - PubMed
  15. Nat Cell Biol. 2013 Mar;15(3):274-83 - PubMed
  16. Cell Stem Cell. 2010 Sep 3;7(3):403-17 - PubMed
  17. Nat Protoc. 2011 May;6(5):656-67 - PubMed
  18. Am J Pathol. 2013 Mar;182(3):975-91 - PubMed
  19. Nat Med. 1997 Jul;3(7):730-7 - PubMed
  20. Histopathology. 2012 Jan;60(1):59-74 - PubMed
  21. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20111-6 - PubMed
  22. Nat Med. 2009 Aug;15(8):907-13 - PubMed
  23. Nature. 2011 Oct 19;478(7369):399-403 - PubMed
  24. Cancer Cell. 2009 Jan 6;15(1):45-56 - PubMed
  25. Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6124-9 - PubMed
  26. Science. 2010 Jul 30;329(5991):568-71 - PubMed
  27. Nat Rev Cancer. 2008 Oct;8(10):755-68 - PubMed

Publication Types

Grant support